INmune Bio
INMB
INMB
66 hedge funds and large institutions have $28.8M invested in INmune Bio in 2024 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.05% more ownership
Funds ownership: 23.09% → 24.14% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
28% less capital invested
Capital invested by funds: $40.3M → $28.8M (-$11.4M)
Holders
66
Holding in Top 10
1
Calls
$2M
Puts
$308K
Top Buyers
| 1 | +$1.59M | |
| 2 | +$765K | |
| 3 | +$682K | |
| 4 |
Millennium Management
New York
|
+$592K |
| 5 |
Renaissance Technologies
New York
|
+$578K |
Top Sellers
| 1 | -$377K | |
| 2 | -$215K | |
| 3 | -$194K | |
| 4 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$191K |
| 5 |
AGM
Alpine Global Management
New York
|
-$102K |